• Our Company

    Allegrow Biotech started in March 2022, and we are now a proud incubatee of the IncuBio Program at the Hong Kong Science and Technology Parks.

    Our vision is to decode complex cell surface signalling pathways to develop the next generation of cell therapy products that combine quality and cost-effectiveness.

    We bring together bioengineering, cell biology and data science expertise to deliver immunomodulation solutions for both research and clinical applications.

  • Our Journey so far

    There are no published blog posts yet.
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More